233 related articles for article (PubMed ID: 24210679)
1. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
Hafiane A; Jabor B; Ruel I; Ling J; Genest J
Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
[TBL] [Abstract][Full Text] [Related]
2. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
4. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
[TBL] [Abstract][Full Text] [Related]
5. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
[TBL] [Abstract][Full Text] [Related]
6. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
7. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
[TBL] [Abstract][Full Text] [Related]
8. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
[TBL] [Abstract][Full Text] [Related]
9. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.
Koba S; Ayaori M; Uto-Kondo H; Furuyama F; Yokota Y; Tsunoda F; Shoji M; Ikewaki K; Kobayashi Y
J Atheroscler Thromb; 2016 Jul; 23(7):865-77. PubMed ID: 26947596
[TBL] [Abstract][Full Text] [Related]
11. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
[TBL] [Abstract][Full Text] [Related]
13. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
[TBL] [Abstract][Full Text] [Related]
14. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
[TBL] [Abstract][Full Text] [Related]
15. Reconstituted HDL in acute coronary syndromes.
Chenevard R; Hürlimann D; Spieker L; Béchir M; Enseleit F; Hermann M; Flammer AJ; Sudano I; Corti R; Lüscher TF; Noll G; Ruschitzka F
Cardiovasc Ther; 2012 Apr; 30(2):e51-7. PubMed ID: 20840194
[TBL] [Abstract][Full Text] [Related]
16. Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
Roe MT; Ou FS; Alexander KP; Newby LK; Foody JM; Gibler WB; Boden WE; Ohman EM; Smith SC; Peterson ED
Eur Heart J; 2008 Oct; 29(20):2480-8. PubMed ID: 18716006
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome.
Tang X; Mao L; Chen J; Zhang T; Weng S; Guo X; Kuang J; Yu B; Peng D
Sci Rep; 2021 Jun; 11(1):11444. PubMed ID: 34075063
[TBL] [Abstract][Full Text] [Related]
19. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]